6P Circulating tumour cells (CTCs) as biomarkers of resistance to the CDK4/6 inhibitor (CDK4/6i) palbociclib (P) in patients (pts) with ER+/HER2-negative advanced breast cancer (ABC)
Titel:
6P Circulating tumour cells (CTCs) as biomarkers of resistance to the CDK4/6 inhibitor (CDK4/6i) palbociclib (P) in patients (pts) with ER+/HER2-negative advanced breast cancer (ABC)
Auteur:
Galardi, F. Biagioni, C. De Luca, F. Curigliano, G. Minisini, A.M. Bonechi, M. Moretti, E. Risi, E. Migliaccio, I. McCartney, A. Benelli, M. Romagnoli, D. Conti, V. Biganzoli, L. Di Leo, A. Malorni, L.